Stockscreener 앱 받기
1.36
4.62%
0.06
시간 외 거래:
1.36
전일 마감가:
$1.30
열려 있는:
$1.31
하루 거래량:
4.03M
Relative Volume:
0.81
시가총액:
$424.76M
수익:
-
순이익/손실:
$-63.08M
주가수익비율:
-5.037
EPS:
-0.27
순현금흐름:
$-72.53M
1주 성능:
+11.48%
1개월 성능:
+1.49%
6개월 성능:
+13.33%
1년 성능:
+59.55%
1일 변동 폭
$1.30
$1.39
1주일 범위
$1.18
$1.39
52주 변동 폭
$0.515
$1.90
오큐젠 Stock (OCGN) Company Profile
명칭
Ocugen Inc
전화
484-328-4701
주소
11 GREAT VALLEY PARKWAY, MALVERN, PA
OCGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OCGN
Ocugen Inc
|
1.36 | 406.02M | 0 | -63.08M | -72.53M | -0.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
오큐젠 Stock (OCGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-15 | 개시 | Maxim Group | Buy |
| 2023-03-01 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2022-08-23 | 개시 | Mizuho | Buy |
| 2022-06-15 | 재개 | ROTH Capital | Buy |
| 2022-06-02 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-07-26 | 개시 | Noble Capital Markets | Outperform |
| 2021-06-11 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2021-05-07 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-09 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2021-02-04 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
모두보기
오큐젠 주식(OCGN)의 최신 뉴스
JANUS HENDERSON GROUP PLC Acquires Significant Stake in Ocugen Inc - GuruFocus
Ocugen CEO’s Keynote Address Meets Heightened Market Skepticism - Ad-hoc-news.de
Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit - Ocugen
Ocugen, Inc. Chairman and CEO Dr. Shankar Musunuri to Present at Oppenheimer Movers in Rare Disease Summit - Quiver Quantitative
Major Fund Manager Acquires Significant Stake in Ocugen Amid Share Price Weakness - AD HOC NEWS
Ocugen Inc. Stock Falls Friday, Underperforms Market - 富途牛牛
Institutional Backing and Geopolitical Tailwinds for Ocugen - AD HOC NEWS
Ocugen Secures Validating Partnership for Gene Therapy Platform - AD HOC NEWS
How robust is Ocugen Inc. (2H51) stock financial positionMarket Volume Summary & Long Hold Capital Preservation Tips - Newser
Why institutional investors increase stakes in Ocugen Inc. (2H51) stockJuly 2025 Macro Moves & Reliable Volume Spike Trade Alerts - Newser
How Ocugen Inc. (2H51) stock compares with tech leadersEarnings Growth Summary & Weekly Hot Stock Watchlists - Newser
Is Ocugen Inc. (2H51) stock resilient in recession scenarios2025 Stock Rankings & Weekly Watchlist of Top Performers - Newser
Why Ocugen Inc. stock appeals to analystsWeekly Trade Analysis & Risk Controlled Swing Alerts - Newser
Ocugen CEO to Spotlight Gene Therapy Breakthroughs at High-Profile Growth Conference - MSN
Ocugen Inc. stock rises Wednesday, outperforms market - MarketWatch
Can Ocugen Inc. (2H51) stock deliver consistent EPS growth2025 Volatility Report & Safe Capital Growth Stock Tips - Newser
Is Ocugen Inc. (2H51) stock good for long term investingRisk Management & Free Community Consensus Stock Picks - Newser
How the Narrative Surrounding Ocugen Is Shifting After New Licensing and Analyst Developments - Yahoo Finance
Ocugen Inc. stock rises Friday, outperforms market - MarketWatch
Ocugen to Announce Third-Quarter 2025 Results and Business Update on November 5 - MSN
Ocugen Receives FDA Greenlight for Phase 1 Trial of Mucosal COVID-19 Vaccine - MSN
Ocugen Inc 2H51 Stock Analysis and ForecastEarnings Surprise Analysis & Low Cost Capital Trading - earlytimes.in
Ocugen, Inc.Common Stock (NQ: OCGN - Markets Financial Content
Ocugen Inc. stock falls Tuesday, underperforms market - MarketWatch
Ocugen Inc. stock rises Monday, outperforms market - MarketWatch
OCGN Stock Price and Chart — NASDAQ:OCGN - TradingView
Ocugen, Inc. (OCGN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Ocugen Inc. (2H51) stock outperform energy sector in 20252025 EndofYear Setup & Verified Trade Idea Suggestions - newser.com
Is Ocugen Inc. stock a defensive play in 20252025 Dividend Review & Real-Time Market Trend Scan - newser.com
Why retail investors favor Ocugen Inc. stockWeekly Trend Summary & AI Forecasted Stock Moves - newser.com
Ocugen CEO to Present at NobleCon21—Noble Capital Markets’ Twenty-First Annual Emerging Growth Equity Conference - Ocugen
How Ocugen Inc. (2H51) stock trades after rate cuts2025 Price Action Summary & Verified Technical Signals - newser.com
Ocugen CEO to Present at NobleCon21-Noble Capital Markets’ Twenty-First Annual Emerging Growth Equity Conference - The Manila Times
Ocugen CEO Dr. Shankar Musunuri to Present at NobleCon21 Conference on Advancements in Gene Therapies for Blindness Diseases - Quiver Quantitative
Ocugen CEO to Present at NobleCon21—Noble Capital Markets’ Twenty-First Annual Emerging Growth ... - Herald and News
Ocugen CEO to Present at NobleCon21—Noble Capital Markets’ - GlobeNewswire
Why Ocugen Inc. (2H51) stock could outperform next yearPortfolio Value Summary & AI Optimized Trading Strategy Guides - newser.com
Is Ocugen Inc. showing signs of accumulationSwing Trade & Weekly Top Performers Watchlists - newser.com
How Ocugen Inc. stock reacts to job market data2025 Momentum Check & Low Drawdown Trading Strategies - newser.com
Can Ocugen Inc. stock continue upward trendJuly 2025 Selloffs & Real-Time Volume Analysis - newser.com
Analyzing net buyer seller activity in Ocugen Inc.2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
What hedge fund moves indicate for Ocugen Inc. (2H51) stockRisk Management & Consistent Profit Alerts - newser.com
오큐젠 (OCGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):